Clinical Trials Logo

Cardiac Surgery clinical trials

View clinical trials related to Cardiac Surgery.

Filter by:

NCT ID: NCT03395886 Completed - Cardiac Surgery Clinical Trials

Remifentanil Versus Dexmedetomidine for Post-Cardiac Surgery Patients With Noninvasive Ventilation Intolerance

REDNIVIN
Start date: January 1, 2018
Phase:
Study type: Observational

The aim of this study is to compare the sedation effects between remifentanil and dexmedetomidine in post-cardiac surgical patients who developed noninvasive ventilation (NIV) intolerance.

NCT ID: NCT03390543 Withdrawn - Cardiac Surgery Clinical Trials

The Effect of Simple Needle Guide Device for Ultrasound-guided Internal Jugular Vein Catheterization in Cardiac Surgical Patients

Start date: January 17, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of simple needle guide device for ultrasound-guided internal jugular vein catheterization in cardiac surgical patients

NCT ID: NCT03360838 Recruiting - Clinical trials for Cognitive Impairment

Development of a Prediction Model for Delirium After Cardiac Surgery Using a Novel Self-Administered Preoperative Cognitive Assessment Tool

CogCheck-Valid
Start date: April 16, 2018
Phase:
Study type: Observational

This observational cohort study is designed to validate the CogCheck application as a risk prediction tool for postoperative delirium in patients undergoing cardiac surgery.

NCT ID: NCT03348072 Completed - Cardiac Surgery Clinical Trials

Comparative Study of Survival and Long-term Quality of Life After Cardiac Surgery in Patients Who Are Jehovah's Witnesses

Start date: February 2016
Phase: N/A
Study type: Observational

This is a comparative study on the survival and long-term quality of life of Jehovah's witnesses having undergone a cardiac surgery and having refused blood transfusions for religious reasons. This group will be compared with two other groups having no restrictions on this subject. The purpose of the study is to evaluate the impact of this decision on survival and postoperative quality of life, in the long term.

NCT ID: NCT03347201 Completed - Cardiac Surgery Clinical Trials

Thrombin Generation During Cardiopulmonary Bypass With Titrated Versus Conventional Anticoagulation Management.

THROMBIN
Start date: October 2, 2017
Phase: N/A
Study type: Interventional

In this study, the investigators will be comparing anticoagulation for Cardiopulmonary Bypass (CPB) guided by the Hemostasis Management System (HMS Plus) with the current dosing based on weight and ACT measurements. The primary objective of this study is to determine whether relative to patients with conventional management, those managed with the HMS Plus have improved thrombin generation after CPB. The secondary objective is to determine if patients in the HMS Plus group have reduced blood loss in the first 24 hours following surgery compared with patients in the conventional group.

NCT ID: NCT03346512 Completed - Cardiac Surgery Clinical Trials

Considerations on the Transfusion Threshold in Cardiac Surgery

Start date: February 2016
Phase:
Study type: Observational

This is a retrospective observational study of the transfusion threshold in cardiac surgery. There is controversy in the literature regarding the transfusion threshold to be adopted, especially in a patient who has undergone cardiac surgery. Some authors suggest that the transfusion should be done in a restrictive way when a certain threshold in hemoglobin is reached, in order to avoid the risks it implies, especially infectious.This threshold is very controversial and remains to be defined (variations in the literature from 7g / dL to 9g / dL). Other authors conclude that there is no superiority of a restrictive transfusion compared to a more liberal transfusion, with regard to the morbidity or medical costs. It is therefore interesting to study, in a retrospective manner, the global and multidisciplinary management of patients who have undergone a cardiac surgery within the CHU Brugmann hospital, to analyze if they have been adequately transfused.

NCT ID: NCT03316183 Not yet recruiting - Cardiac Surgery Clinical Trials

Cerebral Monitor Guided Therapy on Cerebral Outcomes After Cardiac Surgery

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to compare patients' metabolomic profiles who are managed with a brain monitor that measures cerebral oxygen to those who are managed by conventional measures to hopefully decrease postoperative neurologic and cognitive deficits and improve quality of life.

NCT ID: NCT03309839 Completed - Cardiac Surgery Clinical Trials

HLA-DR Expression in Neonates After Cardiac Surgery Under Cardiopulmonary Bypass

IMMUNOPED
Start date: January 29, 2018
Phase:
Study type: Observational

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in neonates who underwent cardiac surgery with cardiopulmonary bypasss. We hypothesize that HLA-DR expression in neonates is predictive of septic complications after cardiopulmonary bypass

NCT ID: NCT03306732 Completed - Cardiac Surgery Clinical Trials

Thiamine Supplementation in High Risk Cardiac Surgery Patients

APPLY
Start date: October 19, 2017
Phase: Phase 4
Study type: Interventional

This pilot trial will evaluate the ability of thiamine to affect on postoperative vasoplegia in high risk cardiac surgery patients

NCT ID: NCT03302286 Completed - Cardiac Surgery Clinical Trials

Effects of Extra Corporeal Circuit Prime on Electrolytes Balance and Clinical Outcome Following Cardiac Surgery

Prime
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

About 6000 heart operations are performed in Sweden every year. A heart-lung machine is used almost exclusively in all heart operations. This machine fills the role of heart and lungs during surgery while the heart is stopped. The extra corporeal circuit (ECC) prime results in hemodilution, as assessed from the decrease in haematocrit, electrolyte concentration and total protein content. This hemodilution is an unavoidable consequence of the use of a heart-lung machine with nonblood ECC prime. The alteration of the patient´s blood volume and electrolytes is affected by the prime solution and can be maintained within normal limits. There are no clear recommendation regarding prime components and numerous prime solutions are in use worldwide. The aim of this study is to investigate whether the use of mannitol in heart-lung machine prime has an effect on electrolytes levels and osmolality when compared with patients who receive no Mannitol.